Canadian Journal of Bioethics-Revue Canadienne de Bioethique, published by the Universite de Montreal, is a premier open-access journal dedicated to advancing the multidisciplinary field of bioethics since 2012. Emphasizing the complexities of ethical practices in health policy, it serves as a vital resource for researchers, professionals, and students engaged in health and philosophy. With its E-ISSN 2561-4665, the journal's content is freely accessible, fostering knowledge dissemination and academic collaboration. Although categorized in Q4 among Health Policy and Health (social science) in 2023, it holds a respectable Q2 status in Philosophy, reflecting its strong theoretical contributions. Covering a wide scope from 2018 to 2024, the journal encourages robust discourse on pressing ethical issues facing contemporary healthcare systems. For those seeking to connect with the evolving narratives in bioethics, this journal is indispensable.

Linacre Quarterly, published by SAGE Publications Inc, is a distinguished journal that serves as an interdisciplinary platform in the fields of Health Policy and Philosophy. With an ISSN of 0024-3639 and an E-ISSN of 2050-8549, this journal has been pivotal in providing insights into the intricate dynamics of health policy through a philosophical lens since its inception in 1945. Notably, it holds a respectable 2023 Scopus rank, placing it in the 68th percentile within the Arts and Humanities (Philosophy) category and the 21st percentile in Medicine (Health Policy). Though currently not offering Open Access options, Linacre Quarterly remains committed to advancing scholarly discussion and fostering innovation among researchers, professionals, and students alike. Located in the United Kingdom, this journal continues to uphold its reputation as a vital resource for those navigating the complexities of health-related ethical dilemmas and policy-making frameworks, thereby enhancing its visibility and relevance in academic discourse.

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.

Developing World Bioethics, published by WILEY, is an esteemed journal dedicated to the exploration and advancement of ethical issues in health and healthcare within developing countries. Since its inception in 2001, this journal has become a critical platform for disseminating scholarly research and discourse that address complex bioethical challenges in varied socio-economic contexts. With an impressive Q2 ranking in multiple categories, including Health Policy and Issues, Ethics and Legal Aspects, it stands out as a vital resource among its peers, boasting significant Scopus rankings that highlight its influence and contribution to the fields of health and social sciences. The journal is committed to fostering interdisciplinary dialogue and insight, making it an invaluable asset for researchers, professionals, and students keen on bioethics and health policy. While the journal operates on a subscription basis, it provides broad access to its diverse range of articles, ensuring that cutting-edge bioethical perspectives are available to stakeholders worldwide, with a focus on innovative solutions and best practices in healthcare systems globally.

Christian Bioethics is a pivotal journal published by Oxford University Press, dedicated to the interdisciplinary exploration of bioethical issues from a Christian perspective. Since its inception in 1995, the journal has served as a crucial platform for scholars, practitioners, and students to engage with complex ethical questions at the intersection of medicine, philosophy, and religious studies. With an evolving scope that reflects contemporary debates in bioethics, the journal has achieved notable rankings, including Q2 in Religious Studies and Q3 in Philosophy in 2023, underscoring its significance in these fields. While not open access, Christian Bioethics continues to bridge gaps between faith and science, encouraging rigorous dialogue on how Christian ethics can inform bioethical decision-making and policy. It is essential reading for those looking to deepen their understanding of ethical issues shaped by religious convictions, making it an invaluable resource for researchers and professionals alike.

PERSPECTIVES IN BIOLOGY AND MEDICINE, published by the esteemed Johns Hopkins University Press, has been a cornerstone of interdisciplinary dialogue since its inception in 1957. With a rich history spanning over six decades, this journal delves into the multifaceted interactions between biology and medicine, offering insights that are vital for health policy, ethics, and the philosophy of science. Recognized for its impact, it holds a Q2 ranking in the History and Philosophy of Science category and Q3 rankings in several other relevant fields as of 2023. While not an open-access publication, it provides critical analyses and discussions that are indispensable for researchers, professionals, and students alike. With its committed editorial team, PERSPECTIVES IN BIOLOGY AND MEDICINE continues to foster scholarly engagement and is poised to shape the future discourse in the biosciences.

Monash Bioethics Review, published by SPRINGER HEIDELBERG, is a leading journal in the interdisciplinary realm of bioethics, dedicated to exploring critical issues at the intersection of health policy, philosophy, and the social sciences. With an impressive impact factor placing it in Q1 in Philosophy and notable rankings across disciplines, including Q3 in Health Policy and Medicine, it serves as an essential platform for researchers, professionals, and students alike. This journal not only aims to foster robust discourse on ethical dilemmas but also seeks to contribute to policymaking through rigorous analysis and research. Covering articles from its inception in 1994 to the present, Monash Bioethics Review remains committed to addressing contemporary ethical challenges in medicine and society, making it a vital resource for those keen on navigating the complexities of bioethical thought.

BioLaw Journal-Rivista di Biodiritto, published by UNIV TRENTO, FAC LAW, stands as a vital interdisciplinary platform in the domains of biolaw, biotechnology, and health policy. With an ISSN of 2284-4503 and a burgeoning reputation, this journal encourages critical discussions surrounding the ethical, legal, and social implications of biotechnological advancements from 2014 to 2024. Ranked Q3 in both Biochemistry and Biotechnology, alongside Q2 rankings in Law and Philosophy, it reflects a growing body of scholarship in these experimental fields. Although currently categorized with varying percentile ranks in the Scopus database, it underlines the journal's commitment to nurturing innovative research and interdisciplinary dialogue. The journal promotes open access principles, although the specific access options should be verified for each article. It serves as an indispensable resource for researchers, professionals, and students engaged in the evolving intersection of law and biotechnology, making it a key player in shaping future discourses in bioethics and policy.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

BIOETHICS is a leading academic journal published by Wiley, dedicated to exploring the multifaceted issues at the intersection of healthcare, philosophy, and policy. With an ISSN of 0269-9702 and an E-ISSN of 1467-8519, it has established itself as a critical platform for scholarly discourse since its inception in 1987. The journal holds impressive rankings, featuring in the Q1 category in both Health (social science) and Philosophy, alongside a Q2 rating in Health Policy for 2023. This positions BIOETHICS in the top echelons of its fields, ranking 35th out of 806 in Philosophy and garnering high percentiles across relevant disciplines. By fostering a deeper understanding of ethical implications in medical and social contexts, BIOETHICS serves as an essential resource for researchers, professionals, and students committed to addressing contemporary challenges in health and policy. The journal is accessible through institutional subscriptions and offers an engaging platform for the dissemination of significant research findings and theoretical advancements, paving the way for future exploration in bioethical inquiry.